A Systematic Review of Outcomes and Quality Measures in Adult Patients Cared for by Hospitalists vs Nonhospitalists
- 534 Discontinuation of heart failure medical therapy in a disease management programme predicts poorer outcome and increased costs. Mockler, M.; O'Loughlin, C.; Conlon, C.; Mcdonald, K.; Ledwidge, M. // European Journal of Heart Failure. Supplements;
The article presents an abstract of the study "Discontinuation of Heart Failure Medical Therapy in a Disease Management Programme Predicts Poorer outcome and increased costs," by M. Mockler and colleagues.
- The type of acute heart failure significantly affects the costs of hospitalization. Harjola, V.-P.; Ylikangas, S.; Costa, S.; Sund, R.; Siirila-Waris, K.; Melin, J.; Peuhkurinen, K.; Nieminen, M.S. // European Journal of Heart Failure. Supplements;Jun2008, Vol. 7 Issue 1, p59
An abstract of the article "The type of acute heart failure significantly affects the costs of hospitalization," by V. P. Harjola and colleagues is presented.
- Invasive therapy warranted among elderly with CAD. // PharmacoEconomics & Outcomes News;1/29/2005, Issue 470, p6
Presents the results of a study on the cost effectiveness of using an invasive therapy in treating elderly patients with chronic symptomatic coronary artery disease. Use of an economic analysis model of invasive therapy which includes coronary angiography followed by revascularization;...
- Controversy over cost effectiveness of drug-eluting stents. // PharmacoEconomics & Outcomes News;2/25/2006, Issue 497, p5
Discusses research on the cost effectiveness of drug eluting coronary artery stenting in patients in Great Britain. Reference to a study by A. Bagust et al, published in the January 2006 issue of the "Heart"; Analysis of data from patients who received stent placements; Risk of repeat...
- Utility of Brain Natriuretic Peptide (BNP) Measurement in Cardiovascular Disease. Sullivan, David R.; West, Malcolm; Jeremy, Richmond // Heart, Lung & Circulation;Jun2005, Vol. 14 Issue iss2, p78
Cardiac failure is a prevalent and costly condition in Western society. The ageing of the population, together with current medical options which improve, rather than eradicate heart failure, lead to the projection that this problem will increase substantially in the foreseeable future. The...
- End-of-life costs on the rise for patients with HF in US and Canada. // Cardiology Today;Nov2010, Vol. 13 Issue 11, p23
This article discusses two studies published in the "Archives of Internal Medicine" which examined the use of health care resources at the end of life and the associated costs in patients with heart failure.
- Health care costs of heart failure: results from a randomised study of patient education. Linné, A. Björck; Liedholm, H.; Jendteg, S.; Israelsson, B. // European Journal of Heart Failure;Sep2000, Vol. 2 Issue 3, p291
Background:: Heart failure is a serious syndrome with a bad prognosis. Hospitalisation is common and readmittance rate is high; factors which influence the cost of care and treatment. Only scarce data on detailed patient materials regarding health care costs are known.
- Cost of HF care projected to double by 2030. Dellapena, Deb; Foster, Melissa // Cardiology Today;Jun2013, Vol. 16 Issue 6, p1
The article reports on the increase in the direct and indirect costs to treat heart failure (HF) by 2030, as projected by the American Heart Association (AHA).
- Decision-Analytic Models to Simulate Health Outcomes and Costs in Heart Failure: A Systematic Review. Goehler, Alexander; Geisler, Benjamin P.; Manne, Jennifer M.; Jahn, Beate; Conrads-Frank, Annette; Schnell-Inderst, Petra; Gazelle, G. Scott; Siebert, Uwe // PharmacoEconomics;2011, Vol. 29 Issue 9, p753
Chronic heart failure (CHF) is a critical public health issue with increasing effect on the healthcare budgets of developed countries. Various decisionanalytic modelling approaches exist to estimate the cost effectiveness of health technologies for CHF. We sought to systematically identify these...